XML 50 R40.htm IDEA: XBRL DOCUMENT v3.2.0.727
Segment Data (Tables)
 9 Months Ended
Jun. 26, 2015
Segment Reporting [Abstract]  
Schedule of Segment Reporting Information by Business Segment
Selected information by business segment was as follows:

Three Months Ended
 
Nine Months Ended

June 26,
2015

June 27,
2014
 
June 26,
2015
 
June 27,
2014
Net sales:



 
 
 
 
Specialty Brands
$
446.2


$
84.9

 
$
1,154.1

 
$
199.6

Specialty Generics
307.9

 
329.4

 
954.9

 
848.5

Global Medical Imaging
201.6


227.1

 
603.5

 
668.1

Net sales of operating segments (1)
955.7


641.4

 
2,712.5

 
1,716.2

Other (2)
9.4


11.7

 
28.8

 
34.9

Net sales
$
965.1


$
653.1

 
$
2,741.3

 
$
1,751.1

Operating income:



 
 
 
 
Specialty Brands
$
189.2


$
(51.4
)
 
$
434.8

 
$
(85.8
)
Specialty Generics
157.2

 
177.0

 
501.4

 
430.3

Global Medical Imaging
34.6


11.2

 
77.1

 
25.9

Segment operating income
381.0


136.8

 
1,013.3

 
370.4

Unallocated amounts:





 
 
 
 
Corporate and allocated expenses (3)          
(74.7
)

(63.6
)
 
(224.2
)
 
(161.5
)
Intangible asset amortization
(149.6
)

(51.6
)
 
(398.7
)
 
(75.9
)
Restructuring and related charges, net (4)
(23.1
)

(24.2
)
 
(34.2
)
 
(54.0
)
Separation costs
—


(1.8
)
 
—

 
(6.6
)
Operating income
$
133.6

 
$
(4.4
)
 
$
356.2

 
$
72.4

(1)
Amounts represent sales to external customers.
(2)
Represents products that were sold to the Company's former parent company, which is discussed in Note 14.
(3)
Includes administration expenses and certain compensation, environmental and other costs not charged to the Company's operating segments.
(4)
Includes restructuring-related accelerated depreciation of $0.4 million for the three months ended June 27, 2014, and $0.2 million and $0.5 million for the nine months ended June 26, 2015 and June 27, 2014, respectively.
Schedule of Net Sales from External Customers by Products
Net sales by product family within the Company's segments are as follows:
 
Three Months Ended
 
Nine Months Ended
 
June 26, 2015
 
June 27, 2014
 
June 26, 2015
 
June 27, 2014
Acthar
$
268.7

 
$
—

 
$
763.1

 
$
—

Ofirmev
62.1

 
53.2

 
201.6

 
58.5

Inomax
81.5

 
—

 
81.5

 
—

EXALGO®
8.6

 
8.6

 
32.7

 
73.7

Other
25.3

 
23.1

 
75.2

 
67.4

Specialty Brands
$
446.2

 
$
84.9

 
$
1,154.1

 
$
199.6

 
 
 
 
 
 
 
 
Oxycodone (API) and oxycodone-containing tablets
$
31.6

 
$
53.8

 
$
127.2

 
$
101.7

Hydrocodone (API) and hydrocodone-containing tablets
37.4

 
25.3

 
138.0

 
75.1

Methylphenidate ER
30.0

 
54.7

 
112.6

 
154.3

Other controlled substances
157.4

 
154.4

 
414.7

 
408.6

Other
51.5

 
41.2

 
162.4

 
108.8

Specialty Generics
$
307.9

 
$
329.4

 
$
954.9

 
$
848.5

 
 
 
 
 
 
 
 
Optiray™
$
58.5

 
$
76.0

 
$
177.5

 
$
219.4

Other
34.3

 
40.7

 
105.8

 
121.5

Contrast Media and Delivery Systems
92.8

 
116.7

 
283.3

 
340.9

Nuclear Imaging
108.8

 
110.4

 
320.2

 
327.2

Global Medical Imaging
$
201.6

 
$
227.1

 
$
603.5

 
$
668.1